Mode
Text Size
Log in / Sign up
N/A Completed N=100 Randomized Treatment

A Trial of Mechanical Axis vs Kinematic Alignment in Total Knee Replacement

Arthroplasties · Knee Replacement
Source: ClinicalTrials.gov NCT02527148 ↗
Enrolled (actual)
100
Serious AEs
77.8%
Results posted
Jan 2016
Primary outcomePrimary: Oxford Knee Score — 20.3; 21.1; 32.5; 32.8 units on a scale — p=<0.0001

Summary

This is a prospective, randomized, longitudinal study of the clinical outcomes of osteoarthritis patients treated by two different alignment philosophies for total knee replacement. In this study ShapeMatch® cutting guides will be compared to the conventional approach.

Outcome Measures

OutcomeResultp-value
PRIMARY
Oxford Knee Score
20.3; 21.1; 32.5; 32.8; 41.0; 38.2 <0.0001 sig
SECONDARY
Cost Effectiveness: Total Duration of Operating Procedure (Anaesthetic Time and Skin-to-skin Incision Time)
82.6; 92.2 0.10
SECONDARY
Cost Effectiveness: Wound Length
223; 233 0.05
SECONDARY
Cost Effectiveness: Cost of Consumable Items Used During Operating Procedure
— —
SECONDARY
Cost Effectiveness: Length of Stay in Hospital
5.1; 4.2 0.07
SECONDARY
Cost Effectiveness: Quality-adjusted Life-years (QALYs) From EQ-5D-3L
0.507; 0.484; 0.895; 0.852 0.55
SECONDARY
Knee Pain
4.36; 4.20; 5.78; 6.01; 1.95; 1.79 0.7240
SECONDARY
The Western Ontario and McMaster Universities Arthritis Index (WOMAC)
50.05; 50.36; 74.74; 73.06; 87.89; 81.79 0.911
SECONDARY
Health-related Quality of Life (EQ-5D-3L)
0.51; 0.48; 71.43; 75.66; 0.67; 0.68 0.452
SECONDARY
The Forgotten Joint Score (FJS-12)
58.12; 57.21; 60.47; 59.96; 62.47; 62.01 0.523
SECONDARY
The International Knee Society Score (IKSS)
40.20; 37.33; 54.06; 55.50; 118.07; 116.17 0.3768
SECONDARY
Perth CT Protocol
-0.4; -0.7; 2.0; 0.6; -2.8; -0.7 0.6

Eligibility Criteria

Inclusion Criteria

  • The patient is a male or non-pregnant female between the ages of 40-80 years.
  • The patient requires a primary total knee replacement and is indicated for computer-assisted surgery.
  • Patient is deemed appropriate for a cruciate retaining knee replacement.
  • The patient has a primary diagnosis of osteoarthritis (OA).
  • The patient has intact collateral ligaments.
  • The patient is able to undergo MRI scanning of the affected limb.
  • The patient has signed the study specific, ethics-approved, Informed Consent document.
  • The patient is willing and able to comply with the specified pre-operative and post-operative clinical and radiographic evaluations.

Exclusion Criteria

  • The patient has a history of total, unicompartmental reconstruction or fusion of the affected joint.
  • Patient has had a previous osteotomy around the knee.
  • The patient is morbidly obese (BMI ≥ 40).
  • The patient has a deformity which will require the use of stems, wedges or augments in conjunction with the Triathlon Total Knee System.
  • The patient has a varus/valgus malalignment ≥ 15° (relative to mechanical axis).
  • The patient has a fixed flexion deformity ≥ 15°.
  • The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
  • The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
  • Patient has a cognitive impairment, an intellectual disability or a mental illness.
  • The patient is pregnant.
  • The patient has metal hardware present in the region of the hip, knee or ankle (as this is known to create geometrical distortion in the region of the implant).
  • The patient has any known contraindications for undergoing assessment by MRI (e.g. ferrous implants, metallic clips, magnetically activated implanted devices such as cardiac pacemakers, etc).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02527148). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search